StonvexLoading…
StonvexStonvexStonvexCore line items from GRMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.25B | $6.30B | $5.23B | $4.86B |
Operating Income | $1.88B | $1.59B | $1.09B | $1.03B |
Net Income | $1.66B | $1.41B | $1.29B | $973.59M |
EPS (Diluted) | $8.59 | $7.30 | $6.71 | $5.04 |
Total Assets | $10.99B | $9.63B | $8.60B | $7.73B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.28B | $2.08B | $1.69B | $1.28B |
Free Cash Flow OCF − CapEx | $1.36B | $1.24B | $1.18B | $543.97M |
Shares Outstanding | 192.62M | 192.47M | 191.78M | 191.62M |